Postoperative adjuvant chemotherapy for gastric cancer
作者： Koichi Okabe
DOI:
关键词: Tegafur 、 Stage ii 、 Cancer 、 Gastroenterology 、 Surgery 、 Dosing 、 Internal medicine 、 Drug holiday 、 Surgical operation 、 Adjuvant chemotherapy 、 Survival rate 、 Medicine
摘要: A method of treating gastric cancer that is a postoperative adjuvant chemotherapy for characterized by comprising orally administering to patient suffering from in stage II, IIIA or IIIB the classification extent medicinal composition, which contains Tegafur, Gimeracil and Oteracil potassium at molar ratio 1:0.4:1, dose 50 150 mg/day terms Tegafur according dosing schedule consisting of, within 45 days after surgical operation, 28 consecutive administration followed 7- 14-day drug holiday. This reduces rate recurrence operation elevates survival rate.
lens.org 参考文章(3)
Taira Kinoshita, Atsushi Nashimoto, Yoshitaka Yamamura, Takeshi Okamura, Mitsuru Sasako, Junichi Sakamoto, Hiroshi Kojima, Masahiro Hiratsuka, Kuniyoshi Arai, Motonori Sairenji, Norimasa Fukushima, Hironobu Kimura, Toshifusa Nakajima, Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer Gastric Cancer. ,vol. 7, pp. 104- 109 ,(2004) , 10.1007/S10120-004-0278-3
Motohiro Hirao, Kazumasa Fujitani, Toshimasa Tsujinaka, Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding. Hepato-gastroenterology. ,vol. 50, pp. 889- 892 ,(2003)
Nakajima Toshifusa, Takagi Shigeru, METHOD OF CURING STOMACH CANCER ,(2006)